Kincell Bio partners with innovators to advance autologous and allogeneic cell therapies for patients in need of therapeutic solutions. With manufacturing facilities located in Research Triangle Park, NC, and Gainesville, FL, Kincell Bio is a Cell therapy CDMO with the mission to streamline CMC development, apply expertise in analytical and process development, and facilitate quality-first, reliable GMP supply from early clinical to pivotal studies and product launch.
Kincell Bio’s platform offers clients a personalized, responsive, and expert-driven approach to process development and manufacturing from early clinical to pivotal supply and commercial launch, ensuring rapid timelines without compromising on quality.
Company Details
- Employees
- 67
- Founded
- -
- Address
- 20 Tw Alexander Dr, Suite 130,united States
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://kincellbio.com
- Keywords
- non-viral delivery technologies, early phase cell therapy, manufacturing GMP grade, CMC support, Cell Therapy CDMO, Analytical development, CAR-T/CAR-M/CAR-NK, TCR-T, Differentiated iPSC, TRegs.
- HQ
- Durham, NC
Kincell Bio Questions
Kincell Bio's website is https://kincellbio.com
Kincell Bio's LinkedIn profile is https://www.linkedin.com/company/kincellbio
Kincell Bio has
67 employees.
View email and phone details for 67
employees at Kincell Bio.
Kincell Bio's industry is
Pharmaceutical Manufacturing
Kincell Bio's top competitors are
Resilience,
Exmoor Pharma,
Ascend Advanced Therapies,
Inceptor Bio,
Imugene Limited,
Fujifilm Biotechnologies,
Catalent,
Genezen,
Cellipont Bioservices,
Kbi Biopharma.
Kincell Bio's categories are Pharmaceutical Manufacturing
Kincell Bio's founding year is 2023
